News - Archive

• October, 14   2009
  Nerviano Medical Sciences: the SIF – Farmindustria prize for pharmacological research awarded to Paolo Cappella
  
  
• October, 8   2009
  In JCO, Danusertib results of a Phase 1 trial. Phase 2 in patients with lung cancer and other solid tumors ongoing.
  
  
• September, 25   2009
  Dr. Artur Góra guest at the Oncology Seminar at Nerviano Medical Sciences
  
  
• May, 22   2009
  Prof Menico Rizzi guest at the Oncology Seminars at Nerviano Medical Sciences
  
  
• May, 19   2009
  30 MILLION FOR NMS: THE RECAPITALIZATION HAS BEEN COMPLETED.
  
  
• May, 13   2009
  Nerviano Medical Sciences receives approval from the FDA to enter Phase I clinical trials for their Polo Like Kinase (PLK) inhibitor
  
  
• May, 6   2009
  Prof Walid Houry guest at the Oncology Seminars at Nerviano Medical Sciences
  
  
• February, 20   2009
  Prof. Salvatore Siena guest at the Oncology Seminars at Nerviano Medical Sciences
  
  
• February, 13   2009
  Brunangelo Falini guest at the Oncology Seminars at Nerviano Medical Sciences
  
  
• February, 10   2009
  FDA approves clinical studies of a novel anti-cancer drug developed by the Italian research
  
  
• January, 30   2009
  Dr Armando Genazzani guest at the Oncology Seminars at Nerviano Medical Sciences
  
  
• January, 28   2009
  Libro: Darwin contro il cancro
  
  
• January, 16   2009
  Dr Alessandro Rambaldi guest at the Oncology Seminars at Nerviano Medical Sciences
  
  
• December, 12   2008
  Dr Ulrich Pfeffer guest at the Oncology Seminars at Nerviano Medical Sciences
  
  
• November, 21   2008
  Prof. David Parker guest at the Oncology Seminars at Nerviano Medical Sciences
  
  
• November, 14   2008
  Prof. Mauro Magnani guest at the Oncology Seminars at Nerviano Medical Sciences
  
  
• November, 7   2008
  Prof. Antonio De Flora guest at the Oncology Seminars at Nerviano Medical Sciences
  
  
• October, 24   2008
  Dr Luigi Calzolai guest at the Oncology Seminars at Nerviano Medical Sciences
  
  
• October, 23   2008
  Nerviano Medical Sciences invited by EORTC-NCI-AACR to present the state-of-the-art of Aurora
  
  
• October, 21   2008
  Nerviano Medical Sciences announces a new Collaboration Agreement with Genentech to discover Antibody Drug Conjugates
  
  
• October, 10   2008
  Prof. Boudewijn P.F. Lelieveldt guest at the Oncology Seminars at Nerviano Medical Sciences
  
  
• September, 16   2008
  Daniele Donati is the new Director, Medicinal Chemistry of Nerviano Medical Sciences
  
  
• September, 16   2008
  The preparation of biological samples: problems and solutions Accelera is organizing a Study Day at Nerviano Research Centre
  
  
• September, 5   2008
  Enrico Garattini guest at the Oncology Seminars at Nerviano Medical Sciences
  
  
• July, 18   2008
  Arturo Falaschi guest at the Oncology Seminars at Nerviano Medical Sciences
  
  
• July, 4   2008
  Emanuela Colombo guest to Oncology Seminars at Nerviano Medical Sciences
  
  
• June, 27   2008
  The DNDi Project of the Year”: The Development of Fexinidazole to Treat “Sleeping Sickness”.
  
  
• June, 27   2008
  Professor Ruggero De Maria guest to Oncology Seminar at Nerviano Medical Sciences
  
  
• June, 2   2008
  Three Nerviano Medical Sciences molecules at ASCO
  
  
• May, 30   2008
  Bernard Ducommun guest to Oncology Seminar at Nerviano Medical Sciences
  
  
• May, 23   2008
  Giancarlo Pruneri guest to Oncology seminar at Nerviano Medical Sciences
  
  
• May, 23   2008
  Nerviano Medical Sciences adopts three distint strategies to tackle new markets
  
  
• May, 20   2008
  NMS develops a novel approach for cancer treatment
  
  
• May, 16   2008
  Josef Jiricny host to Oncology Seminar at Nerviano Medical Sciences
  
  
• May, 13   2008
  Students face to face with science
  
  
• May, 9   2008
  Dario Neri guest to Oncology Seminar at Nerviano Medical Sciences
  
  
• April, 15   2008
  Important new discoveries from NMS on Cdc7 inhibitor, a protein responsible for the proliferation of tumour cells
  
  
• April, 2   2008
  Hemmo Meyer guest to Oncology Seminar at Nerviano Medical Sciences
  
  
• February, 1   2008
  Carlo La Vecchia guest to Oncology Seminar at Nerviano Medical Sciences
  
  
• January, 9   2008
  Nerviano Medical Sciences and Genentech joint strenghts
  
  
• December, 18   2007
  Giovanni Gaudino guest to Oncology Seminar at Nerviano Medical Sciences
  
  
• December, 4   2007
  David Lloyd guest to Oncology Seminar at Nerviano Medical Sciences
  
  
• November, 23   2007
  Sten Orrenius guest to Oncology seminat at Nerviano Medical Sciences
  
  
• November, 20   2007
  Brostallicin: encouraging results obtained in a clinical trial presented in Naples
  
  
• November, 19   2007
  Nerviano Medical Sciences expands partnership with ChemDiv in lead discovery
  
  
• November, 6   2007
  Tim Bruemmendorf guest to Oncology Seminar at Nerviano Medical Sciences
  
  
• October, 2   2007
  Valentina Bonetto guest to Oncology Seminar at Nerviano Medical Sciences
  
  
• September, 25   2007
  Alberto Mantovani guest to Oncology Seminar at Nerviano Medical Sciences
  
  
• September, 4   2007
  Curzio Rüegg guest to Oncology seminar at Nerviano Medical Sciences
  
  
• July, 25   2007
  Brostallicin, the new oncology drug candidate, discovered by NMS was licensed to CTI
  
  
• July, 17   2007
  UniCredit Banca d'Impresa provides support to scientific research
  
  
• July, 17   2007
  Andrea Ciliberto guest to Oncology seminar at Nerviano Medical Sciences
  
  
• June, 21   2007
  Accelera, Nerviano Medical Sciences, will sponsor the International Isotope Society.
  
  
• June, 19   2007
  Josée Thérèse Golay guest to Oncology Seminar at Nerviano Medical Sciences
  
  
• June, 18   2007
  Massimo Broggini guest to Oncology Seminar at Nerviano Medical Sciences
  
  
• June, 8   2007
  Farmindustria Award 2007 – Assigned to Dr.Bosotti of Nerviano Medical Sciences
  
  
• March, 8   2007
  Nerviano Medical Sciences (NMS) Announces the Launch of Accelera: The New Brand of NMS-Preclinical Development
  
  
• February, 6   2007
  Information security for Nerviano Medical Sciences
  
  
• November, 21   2006
  A new anti-cancer drug discovered by Nerviano Medical Sciences advances towards phase II clinical trials
  
  
• November, 6   2006
  Nerviano Medical Sciences: New anti-tumour drug gives promising results in patients with solid, advanced stage tumours
  
  
• September, 6   2006
  Papilloma Virus. Studies on new vaccines by NMS are presented at the Milan Oncological Congress.
  
  
• September, 6   2006
  World oncological research summit in Milan
  
  
• September, 4   2006
  First results in anti-cancer research for Nerviano Medical Sciences
  
  
• July, 25   2006
  World oncology in milan to discuss targeted therapies
  
  
• July, 18   2006
  Indena and Nerviano Medical Sciences
  
  
• June, 28   2006
  ChemDiv to Supply NervianoMS with Discovery Libraries
  
  
• March, 8   2006
  Two new antitumoural agents
  
  
• February, 28   2006
  Agreement with BMS
  
  
• February, 21   2006
  Scientific research for schools